Citigroup’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.2M | Sell |
1,899,044
-931,940
| -33% | -$27.3M | 0.02% | 643 |
|
|
2025
Q4 | $82M | Buy |
2,830,984
+1,311,982
| +86% | +$39.4M | 0.04% | 434 |
|
|
2025
Q3 | $42.2M | Buy |
1,519,002
+848,733
| +127% | +$21.4M | 0.02% | 703 |
|
|
2025
Q2 | $16.3M | Sell |
670,269
-1,890,491
| -74% | -$41.4M | 0.01% | 1080 |
|
|
2025
Q1 | $53.2M | Buy |
2,560,760
+905,515
| +55% | +$22.7M | 0.03% | 536 |
|
|
2024
Q4 | $39M | Sell |
1,655,245
-25,400
| -2% | -$625K | 0.02% | 623 |
|
|
2024
Q3 | $43M | Buy |
1,680,645
+849,831
| +102% | +$21.6M | 0.02% | 600 |
|
|
2024
Q2 | $19.5M | Sell |
830,814
-77,785
| -9% | -$1.96M | 0.01% | 902 |
|
|
2024
Q1 | $26.1M | Buy |
908,599
+246,877
| +37% | +$7.42M | 0.02% | 768 |
|
|
2023
Q4 | $21.7M | Buy |
661,722
+14,447
| +2% | +$393K | 0.02% | 818 |
|
|
2023
Q3 | $18M | Sell |
647,275
-771,729
| -54% | -$25.2M | 0.01% | 816 |
|
|
2023
Q2 | $48.4M | Buy |
1,419,004
+16,147
| +1% | +$508K | 0.03% | 451 |
|
|
2023
Q1 | $42.2M | Buy |
1,402,857
+1,092,968
| +353% | +$33.9M | 0.03% | 467 |
|
|
2022
Q4 | $8.75M | Sell |
309,889
-99,970
| -24% | -$3.17M | 0.01% | 1203 |
|
|
2022
Q3 | $13.5M | Buy |
409,859
+208,067
| +103% | +$7.64M | 0.01% | 990 |
|
|
2022
Q2 | $6.35M | Sell |
201,792
-150,110
| -43% | -$5.25M | ﹤0.01% | 1389 |
|
|
2022
Q1 | $16.2M | Sell |
351,902
-15,942
| -4% | -$760K | 0.01% | 1038 |
|
|
2021
Q4 | $22.5M | Sell |
367,844
-58,093
| -14% | -$4.02M | 0.01% | 941 |
|
|
2021
Q3 | $31.8M | Buy |
425,937
+92,448
| +28% | +$7.76M | 0.02% | 737 |
|
|
2021
Q2 | $30.8M | Buy |
333,489
+40,489
| +14% | +$3.44M | 0.02% | 771 |
|
|
2021
Q1 | $26M | Buy |
293,000
+260,708
| +807% | +$25.9M | 0.02% | 808 |
|
|
2020
Q4 | $3.01M | Buy |
32,292
+32,157
| +23,820% | +$2.56M | ﹤0.01% | 2478 |
|
|
2020
Q3 | $9K | Hold |
135
| – | – | ﹤0.01% | 6669 |
|
|
2020
Q2 | $7K | Hold |
135
| – | – | ﹤0.01% | 7166 |
|
|
2020
Q1 | $4K | Sell |
135
-70
| -34% | -$2.34K | ﹤0.01% | 7297 |
|
|
2019
Q4 | $7K | Hold |
205
| – | – | ﹤0.01% | 7294 |
|
|
2019
Q3 | $6K | Hold |
205
| – | – | ﹤0.01% | 7255 |
|
|
2019
Q2 | $7K | Hold |
205
| – | – | ﹤0.01% | 7380 |
|
|
2019
Q1 | $7K | Sell |
205
-341
| -62% | -$10.1K | ﹤0.01% | 7330 |
|
|
2018
Q4 | $13K | Buy |
546
+135
| +33% | +$3.8K | ﹤0.01% | 7053 |
|
|
2018
Q3 | $14K | Hold |
411
| – | – | ﹤0.01% | 7231 |
|
|
2018
Q2 | $12K | Hold |
411
| – | – | ﹤0.01% | 7111 |
|
|
2018
Q1 | $11K | Buy |
+411
| New | +$11.1K | ﹤0.01% | 7003 |
|
Other funds holding ARKG
JFG
Citigroup's ARKG Position: Q1 2026 in Review
Citigroup reduced its ARK Genomic Revolution ETF (ARKG) stake by 33% in Q1 2026, selling an estimated $27.3M and leaving 1,899,044 shares worth $50.2M. The position accounts for 0.02% of the portfolio, ranked #643.
Citigroup first reported a position in ARKG in Q1 2018 and has held it in 33 quarters since. The position peaked at $82M in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Citigroup held 1,899,044 shares of ARK Genomic Revolution ETF worth $50.2M as of Q1 2026.
- Citigroup sold 931,940 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $27.3M.
- ARK Genomic Revolution ETF made up 0.02% of Citigroup's portfolio in Q1 2026, its #643 holding.
- Citigroup first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 33 quarters since.
- Citigroup's ARK Genomic Revolution ETF position peaked at $82M in Q4 2025.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.